Press Releases
View Archive: 2010 | 2009 | 2008 | 2007 | 2006 | 2005
November 23, 2009 – Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
August 18, 2009 – Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine™ for Prostate Conditions with Start-Up of Phase 2 BPH Trial
August 12, 2009 – First Pediatric Patient Treated with Aptocine™, a Novel Light-Activated Drug, in Neurofibromatosis Study
January 27, 2009 – Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
